| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Rozov Yadin is a Director at Core Scientific, Inc./tx with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 17 sells.
Estimated insider holdings value: $30.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | DAVE Dave Inc./de | Director | Sell | 4,726 | $228.06 | $1,077,816.16 | -1.2% | -10.9% | - | |
| Sep 4, 2025 | DAVE Dave Inc./de | Director | Sell | 14,660 | $199.54 | $2,925,321.75 | -1.9% | +4.2% | - | |
| Jun 4, 2025 | DAVE Dave Inc./de | Director | Sell | 5,500 | $206.94 | $1,138,147.00 | -2.8% | +1.5% | - | |
| May 28, 2025 | CORZ Core Scientific, Inc./tx | - | Buy | 110,000 | $10.87 | $1,195,370.00 | +30.1% | +30.2% | - | |
| Nov 22, 2024 | CORZ Core Scientific, Inc./tx | - | Sell | 105,000 | $18.11 | $1,901,949.00 | -23.3% | -35.1% | -19.2% | |
| Mar 15, 2024 | CORZ Core Scientific, Inc./tx | - | Buy | 80,000 | $3.07 | $245,968.00 | New | +188.0% | +157.6% | |
| Mar 7, 2024 | DAVE Dave Inc./de | Director | Buy | 800 | $37.31 | $29,848.00 | +0.8% | +1.8% | +124.7% | |
| Dec 4, 2023 | DAVE Dave Inc./de | Director | Buy | 12,941 | $6.40 | $82,760.28 | +15.6% | +235.9% | +1274.8% | |
| Mar 14, 2023 | ORMP Oramed Pharmaceuticals Inc. | Director | Buy | 70,000 | $2.02 | $141,570.00 | +132.1% | +88.0% | +32.5% |